Search Results - "Smart, F. W."

Mycophenolate Mofetil Reduces Intimal Thickness by Intravascular Ultrasound After Heart Transplant: Reanalysis of the Multicenter Trial by Kobashigawa, J. A., Tobis, J. M., Mentzer, R. M., Valantine, H. A., Bourge, R. C., Mehra, M. R., Smart, F. W., Miller, L. W., Tanaka, Koji, Li, Haiyan, Gjertson, D. W., Gordon, R. D.

“…The mycophenolate mofetil (MMF) trial involved 650 heart transplant patients from 28 centers who received MMF or azathioprine (AZA), both in combination with…”
Get full text

Guidelines for the referral and management of patients eligible for solid organ transplantation by STEINMAN, Theodore I, BECKER, Bryan N, FROST, Adaani E, OLTHOFF, Kim M, SMART, Frank W, SUKI, Wadi N, WILKINSON, Alan H

“…Members of the Clinical Practice Committee, American Society of Transplantation, have attempted to define referral criteria for solid organ transplantation…”
Get full text

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus by Taylor, D O, Barr, M L, Radovancevic, B, Renlund, D G, Mentzer, Jr, R M, Smart, F W, Tolman, D E, Frazier, O H, Young, J B, VanVeldhuisen, P

“…Tacrolimus-based immunosuppression seems safe and effective in liver and kidney transplantation. To assess the safety and efficacy of tacrolimus (TAC)-based…”
Get more information

The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal by Mehra, M R, Ventura, H O, Chambers, R B, Ramireddy, K, Smart, F W, Stapleton, D D

“…Our current immunosuppressive strategies have made little impact on the development of cardiac allograft vasculopathy, the leading cause of long-term allograft…”
Get more information

Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy by Mehra, M R, Ventura, H O, Stapleton, D D, Smart, F W, Collins, T C, Ramee, S R

“…The clinical utility of intimal hyperplasia detected by intravascular ultrasonography in predicting cardiac events in heart transplant recipients with cardiac…”
Get more information

Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study by Smart, F W, Naftel, D C, Costanzo, M R, Levine, T B, Pelletier, G B, Yancy, Jr, C W, Hobbs, R E, Kirklin, J K, Bourge, R C

“…By multivariable analysis, risk factors were identified for initial infection of any type, cumulative infections during the first 6 months and fatal infection…”
Get more information

Cardiac allograft vasculopathy: Current concepts by Ventura, Hector O., Mehra, Mandeep R., Smart, Frank W., Stapleton, Dwight D.

“…The major cause of late death in cardiac transplant recipients is cardiac allograft vasculopathy, also referred to as cardiac transplant atherosclerosis, which…”
Get full text

Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study by Mehra, Mandeep R., Ventura, Hector O., Chambers, Richard, Collins, Tyrone J., Ramee, Stephen R., Kates, Marc A., Smart, Frank W., Stapleton, Dwight D.

“…This study was performed to assess the influence and interdependence of immunologic and nonimmunologic risk factors in the development of cardiac allograft…”
Get full text

Safety and clinical utility of long-term intravenous milrinone in advanced heart failure by Mehra, Mandeep R., Ventura, Hector O., Kapoor, Charanjit, Stapleton, Dwight D., Zimmerman, David, Smart, Frank W.

“…Few data are available on the long-term safety or clinical utility of the inodilator agent milrinone. We designed a prospective, nonrandomized, observational…”
Get full text

Valvular regurgitation and right-sided cardiac pressures in heart transplant recipients by complete Doppler and color flow evaluation by Rees, A P, Milani, R V, Lavie, C J, Smart, F W, Ventura, H O

“…To define normal profiles of cardiac structure, function, and hemodynamics postcardiac transplantation using Doppler echocardiography. Retrospective clinical…”
Get more information

Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes by Harjai, K J, Mehra, M R, Ventura, H O, Lapeyre, Y M, Murgo, J P, Stapleton, D D, Smart, F W

“…This study was conducted to assess cost savings and clinical outcomes associated with the use of home i.v. inotropic therapy in patients with advanced (New…”
Get more information

Mitral inflow and pulmonary venous Doppler measurements do not predict pulmonary capillary wedge pressure in heart transplant recipients by Richards, David R., Gilliland, Yvonne, Bernal, J.Alberto, Smart, Frank W., Stapleton, Dwight D., Ventura, Hector O., Cheirif, Jorge

“…Background: Noninvasive estimation of pulmonary capillary wedge pressure (PCWP) with Doppler-derived mitral inflow pattern has been shown to correlate well…”
Get full text

The independent effects of left ventricular ejection fraction on short‐term outcomes and resource utilization following hospitalization for heart failure by Harjai, Kishore J., Nunez, Eduardo, Turgut, Tansel, Shah, Mehul P., Stewart Humphrey, J., Newman, Jeff, Cheirif, Jorge, Smart, Frank W., Ventura, Hector O.

“…While depressed left ventricular ejection fraction is clearly associated with poor long-term outcome in heart failure (HF), the effect of ejection fraction on…”
Get full text

Usefulness of Peak Oxygen Consumption in Predicting Outcome of Heart Failure in Women Versus Men by Richards, David R, Mehra, Mandeep R, Ventura, Hector O, Lavie, Carl J, Smart, Frank W, Stapleton, Dwight D, Milani, Richard V

“…This investigation finds that percent of predicted maximum oxygen consumption, an age- and gender-adjusted measurement of exercise, capacity, describes the…”
Get full text

Elevated expression of proteoglycans in proliferating vascular smooth muscle cells by Tao, Zhuo, Smart, Frank W., Figueroa, Julio E., Glancy, D.Luke, Vijayagopal, Parakat

“…Smooth muscle cell (SMC) proliferation and increased production of arterial wall proteoglycans (PG) are implicated in atherogenesis. We investigated the effect…”
Get full text

Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart by Watanabe, E, Smith, D M, Sun, J, Smart, F W, Delcarpio, J B, Roberts, T B, Van Meter, Jr, C H, Claycomb, W C

“…Administration of growth factors is emerging as a new therapeutic approach for the enhancement of collateral vessel formation in the ischemic heart. We have…”
Get full text

Allograft aortopathy: An in vivo study of donor aorta involvement in cardiac allograft vasculopathy by Mehra, Mandeep R., Ventura, Hector O., Stapleton, Dwight D., Karsan, Arun K., Smart, Frank W., Ramee, Stephen R., Collins, Tyrone J.

“…Limited histopathologic studies of failed cardiac allografts have demonstrated that cardiac allograft vasculopathy extends into the donor aorta; however, no…”
Get full text

Effect of hypoxia and hypoxia/reoxygenation on proteoglycan metabolism by vascular smooth muscle cells by Figueroa, Julio E., Tao, Zhuo, Sarphie, Theodore G., Smart, Frank W., Glancy, D.Luke, Vijayagopal, Parakat

“…Hypoxia and hypoxia/reoxygenation are known to affect vascular smooth muscle cell physiology. In this study, we first investigated proteoglycan synthesis by…”
Get full text

The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift by Mehra, M R, Ventura, H O, Stapleton, D D, Smart, F W

Get more information

Cardiovascular adaptation to cyclosporine-induced hypertension by Ventura, H O, Lavie, C J, Messerli, F H, Valentino, V, Smart, F W, Stapleton, D D, Ochsner, J L

“…Arterial hypertension is a complication of cyclosporine therapy in heart transplant recipients. We studied cardiovascular adaptation to cyclosporine-induced…”
Get more information